COVID-19疫情期间非筛查患者接受乳腺X线摄影的诊断间隔变化
回顾性分析2020年4月1日至6月30日(疫情组,n=77)与2019年同期(疫情前组,n=64)非筛查诊断性乳腺X线摄影患者的诊断间隔。疫情组整体诊断间隔为1天,疫情前组为15天(p<0.0001);无需组织取样者分别为1天与11天(p<0.0001),需取样且病理良性者分别为9天与33天(p=0.0002)。疫情组初次就诊即完成评估的比例为50.6%,疫情前组为23.4%(p=0.0009)。
要点
- 疫情组整体诊断间隔1天,疫情前组15天(p<0.0001),诊断间隔显著缩短。
- 疫情组初次就诊完成评估比例50.6%,疫情前组23.4%(p=0.0009)。
- 作者建议疫情期间乳腺影像部门可考虑重组为快速诊断单元模式并配备导航团队。
核心结论
- COVID-19第一波疫情期间,非筛查诊断性乳腺X线摄影患者的诊断间隔较一年前显著缩短,初次就诊即完成评估的比例更高。
研究设计与样本
- 回顾性病历回顾,疫情组为2020年4月1日至6月30日非筛查诊断性乳腺X线摄影患者(n=77),疫情前组为2019年4月1日至6月30日同类患者(n=64);记录年龄、转诊原因、最终诊断所需的影像检查/活检数量与类型;诊断间隔定义为从诊断性乳腺X线摄影日期至最终诊断日期的天数。
诊断标准与关键数值
- 整体队列诊断间隔:疫情组1天 vs 疫情前组15天(p<0.0001)。
- 无需组织取样者诊断间隔:疫情组1天 vs 疫情前组11天(p<0.0001)。
- 需组织取样且病理良性者诊断间隔:疫情组9天 vs 疫情前组33天(p=0.0002)。
- 初次就诊即完成评估比例:疫情组50.6% vs 疫情前组23.4%(p=0.0009)。
临床应用与阅片要点
- 尽管人力和临床服务减少,疫情期间仍可能为临床高度怀疑乳腺癌的女性维持诊断性乳腺影像服务。
- 作者建议疫情期间乳腺影像部门可考虑重组为快速诊断单元模式,并配备导航团队随访患者至最终诊断。
- 作者认为疫情期间的科室重组和患者导航可能维持或缩短诊断性乳腺X线摄影患者的诊断间隔。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: During the COVID-19 pandemic, there was a temporary cessation of mammography screening. However, in some facilities, diagnostic breast imaging services continued for patients with a high clinical suspicion of breast cancer. The objective of this study was to evaluate changes in the diagnostic interval (DI) of non-screening patients presenting for diagnostic mammography during the first wave of the COVID-19 pandemic.
METHODS: Retrospective chart review was performed on patients presenting for non-screening diagnostic mammography from April 1 to June 30, 2020 (pandemic group) and April 1 to June 30, 2019 (pre-pandemic group). Age, reason for referral, number and type of imaging studies/biopsies necessary for a final diagnosis were recorded. Diagnostic interval (DI) was defined as the number of days from the date of the diagnostic mammogram to the date of the final diagnosis.
RESULTS: Compared to the pre-pandemic group (n = 64), the pandemic group (n = 77) showed a reduction in DI of the entire cohort (pandemic: 1 day; pre-pandemic: 15 days, p < 0.0001) for patients not requiring tissue sampling (pandemic: 1 day; pre-pandemic: 11 days, .p < 0.0001) and those requiring tissue sampling with benign pathology (pandemic 9 days; pre-pandemic, 33 days, p = 0.0002). A higher percentage of patients in the pandemic group had their assessment completed during the initial visit (pandemic: 50.6%; pre-pandemic: 23.4%, p = 0.0009).
CONCLUSION: During the first wave of the COVID-19 pandemic, the DI for patients with non-screening-related diagnostic mammography was significantly shorter, with a higher percentage of patients completing their assessments on the initial visit, compared to one year prior.
KEY POINTS: • Despite reductions in manpower and clinical services, during pandemic times, it is possible to maintain a diagnostic breast imaging service for women at high clinical suspicion for breast cancer. • During pandemic times, breast imaging departments should consider restructuring to a Rapid Diagnostic Unit model with a navigation team that follows patients through the assessment process to a final diagnosis. • Departmental restructuring and patient navigation during pandemic times could either maintain or shorten the diagnostic interval for patients presenting for diagnostic mammography.
引用
- Crivellaro P, Tafur M, George R, et al. Diagnostic interval for non-screening patients undergoing mammography during the COVID-19 pandemic. Eur Radiol. 2021. PMID: 34143286. doi:10.1007/s00330-021-08117-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。